Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-30

Clinical Trial Update: Keratinocyte Skin Cancer Surgery in the Elderly, Aged 80 Years and Over, is Effective and Safe

View source ↗

Summary

Completed trial suggests that keratinocyte skin cancer surgery in patients aged 80 and over is effective and safe. Postoperative outcomes were acceptable.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Juerg Hafner | Conditions: Postoperative Complication | Status: COMPLETED